Tag Archives: National Institutes of Health

NIH & NSF SBIR/STTR Programs

InnovationZone_Logo_SBIR Companies_VERT_lockup

Leveraging Small Business to Bring Life-Saving Innovations to the Market. A key part of the National Institutes of Health (NIH) and the National Science Foundation (NSF)’s mission is the translation of basic discoveries into innovative technologies that improve human health, and the NIH and NSF Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs strive to do just that. NIH is the premier biomedical research funding organization in the world, and has a 2014 SBIR/STTR Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO to Labor/HHS: Increase Funding for Critical Public Health Programs

patient

BIO sent a letter to appropriators to encourage support for programs and initiatives that are of great importance to the American public and the advancement of public health, and that will help meet our nation’s unmet medical needs. Specifically, we request the following: National Institutes of Health (NIH): We request that the Committee provide NIH with at least $32 billion. Since the doubling of the NIH funding between 1998 and 2003, funding has failed to Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

Dent

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, co- chair of the Congressional Biomedical Research Caucus, joined BIO’s Fritz Bittenbender to discuss the biotech industry in Pennsylvania as well as recent legislative developments affecting the industry. Dent points to the recent omnibus spending agreement which allowed the Food and Drug Administration (FDA) to access user $85 million in user fees sequestered in 2013. These fees are paid to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Legislative Hopes, Fears

PNNL Research Scientist Heather Brown

Biotechnology advances are poised now more than ever to help policymakers achieve their goals of supporting innovation in health care, renewable energy, and green technologies. How can they help us? Here are our six hopes (and one big concern) for the term ahead. HOPE 1: Cultivate an atmosphere for patient access to our products While the Congress considers finding savings, do it in a way that does not threaten patient access to drug products by Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

Jim Greenwood

I was recently asked what the single biggest threat to the biotechnology industry is today.  My answer was immediate – the biggest threat to biotech innovation is the unsustainable mismatch of spending and revenue in the U.S. federal budget. The enormous national debt and the huge annual budget deficits that feed it endanger America’s entire economic future – but the nation’s dire fiscal situation is particularly threatening to our industry. Part of the reason for Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,